Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Breyanzi
Pharma
BMS angles Breyanzi for another blood cancer
With another trial win, BMS is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types.
Angus Liu
Feb 10, 2025 9:50am
Pfizer, BMS and more start 2025 with drug price hikes: report
Jan 2, 2025 10:42am
FDA revisits CAR-T boxed warning on secondary cancers: Marks
Nov 1, 2024 10:30am
BMS skates again on $6.4B Celgene shareholder lawsuit
Oct 1, 2024 10:45am
Bristol Myers secures another FDA go-ahead for Breyanzi
May 30, 2024 1:32pm
BMS' Breyanzi bags FDA nod to treat follicular lymphoma
May 16, 2024 10:56am
